Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Wenbo Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9759-0291; OpenAlex author ID A5101627140. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 2 papers · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 8

  1. Recognizing significance of propensity score matching and clinical practice in evaluating oncological survivals of pancreatic cancer. Co-author DOI 10.21037/hbsn-24-615↗
  2. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hbpd.2022.09.009↗
  3. Nomogram predicts risk of perineural invasion based on serum biomarkers for pancreatic cancer. Co-author DOI 10.1186/s12876-023-02819-y↗
  4. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12876-022-02552-y↗
  5. Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1052768↗
  6. Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.770005↗
  7. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic… Co-author DOI 10.1080/21655979.2021.1992331↗
  8. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. First author DOI 10.2217/fon-2021-0495↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Liu · 7 shared papers, 2021–2025 · strength 1.35
  2. Lincheng Li · 4 shared papers, 2021–2022 · strength 0.67
  3. Zhaoda Deng · 3 shared papers, 2022 · strength 0.53
  4. Zhiming Zhao · 2 shared papers, 2023–2025 · strength 0.52
  5. Minggen Hu · 3 shared papers, 2021–2023 · strength 0.49
  6. Ye Xu · 1 shared paper, 2025 · strength 0.33
  7. Gong Zhang · 2 shared papers, 2021–2022 · strength 0.32
  8. Zizheng Wang · 2 shared papers, 2021 · strength 0.30
  9. Xiuping Zhang · 1 shared paper, 2023 · strength 0.19
  10. Shuai Xu · 1 shared paper, 2023 · strength 0.19
  11. Qu Liu · 1 shared paper, 2023 · strength 0.19
  12. Yuan-Shu Lian · 1 shared paper, 2023 · strength 0.18
  13. Gao Huang · 1 shared paper, 2023 · strength 0.18
  14. Jing Wang · 1 shared paper, 2022 · strength 0.15
  15. Fei Wang · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.